| 000 | 01823 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250514015657.0 | ||
| 264 | 0 | _c20030610 | |
| 008 | 200306s 0 0 eng d | ||
| 022 | _a0169-5002 | ||
| 024 | 7 |
_a10.1016/s0169-5002(01)00279-3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aChoy, H | |
| 245 | 0 | 0 |
_aPhase I trial of outpatient weekly docetaxel, carboplatin and concurrent thoracic radiation therapy for stage III unresectable non-small-cell lung cancer: a Vanderbilt cancer center affiliate network (VCCAN) trial. _h[electronic resource] |
| 260 |
_bLung cancer (Amsterdam, Netherlands) _cDec 2001 |
||
| 300 |
_a441-9 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aCarboplatin _xadministration & dosage |
| 650 | 0 | 4 |
_aCarcinoma, Non-Small-Cell Lung _xdrug therapy |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 | _aDocetaxel |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLung Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPaclitaxel _xadministration & dosage |
| 650 | 0 | 4 | _aTaxoids |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aDeVore, R F | |
| 700 | 1 | _aHande, K R | |
| 700 | 1 | _aPorter, L L | |
| 700 | 1 | _aRosenblatt, P A | |
| 700 | 1 | _aSlovis, B | |
| 700 | 1 | _aLaporte, K | |
| 700 | 1 | _aShyr, Y | |
| 700 | 1 | _aJohnson, D H | |
| 773 | 0 |
_tLung cancer (Amsterdam, Netherlands) _gvol. 34 _gno. 3 _gp. 441-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0169-5002(01)00279-3 _zAvailable from publisher's website |
| 999 |
_c11629144 _d11629144 |
||